Search

Search Constraints

You searched for: Author/Creator Cozzi‐Lepri, A

Search Results

1. Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data1. Issue 5 (14th January 2015)

2. Evolution of major non‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014. Issue 2 (21st November 2018)

3. First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison. Issue 7 (30th May 2018)

5. Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe. Issue 3 (14th September 2016)

6. Incidence and factors associated with the risk of sexually transmitted diseases in HIV‐infected people seen for care in Italy: data from the Icona Foundation cohort. Issue 7 (11th May 2015)

7. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens. Issue 2 (6th October 2017)

8. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe. Issue 5 (1st February 2018)

9. Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study. Issue 5 (25th December 2020)